Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Atezolizumab plus nab-paclitaxel prolonged progression-free survival among patients with metastatic triple-negative breast cancer in both the intention-to-treat population and t...